For our Clinical Safety and Pharmacovigilance team in the Research and Development department based in Lausanne we are looking for a:
100%, Permanent contract, in Lausanne HQ.
In this role, you will be responsible for actively managing and evaluating risks associated with products in development in oncology and also antibiotics under the responsibility of the Head of Clinical Safety and Pharmacovigilance. You will also support deployment of the early phases in healthy volunteers in collaboration with the Clinical Pharmacology & Drug Metabolism team
Your responsibilities will be but not limited to:
Requirements
Your profile
· M.D., with experience in clinical safety in early clinical phases of drug development in a global pharmaceutical or global CRO
· At least 5 years of direct experience in Biotech/Pharmaceutical industry in clinical safety
· First experience in oncology drug development, in early stages an asset
· Excellent leadership, management, collaboration, communication and decision making skills
· Able to prioritize activities effectively and to meet multiple deadlines successfully with attention to detail, setting high performance standards for quality
· Master Microsoft 365 suite, appetite for digital tools a plus
· Demonstrate excellent written and verbal communication skills in English, French an asset
Benefits
Debiopharm offers employees:
· International, highly dynamic environment with a long-term vision.
· Cross-functional collaboration at the forefront of the most advanced scientific developments in oncology and anti-bacterial industry
· Exposure to a wide variety of areas and functions within clinical development and the pharmaceutical industry
· Participation in a company where innovation, people and entrepreneurship are the fundamental keys to success.
· Proud to be an Equal-Pay certified, we ensure offering to all our employees the same opportunities
The use of external staffing agencies or recruiters requires prior approval from our Human Resources Department. The Human Resources Department at Debiopharm requests external staffing agencies or recruiters not to contact Debiopharm employees or members of the Board of Directors directly in an attempt to present candidates.
Submission of unsolicited resumes in advance of an agreement between the Human Resources Department and the external staffing agency or recruiter does not create any implied obligation on the part of Debiopharm.
Debiopharm will not accept unsolicited resumes from any source other than candidates themselves for either current or future positions.

Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe.
Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections.
Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®
If your university or biotech start-up has interesting molecules in early-stage research and you’re seeking a competent and committed partner to develop them further, please contact us!